Re: 'Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe' by Lange et al
Clinical microbiology and infection.
2024 Sep ;
30 (9) :
1204-1206.
[epub] 20240606
Language English Country Great Britain, England Media print-electronic
Document type Letter, Comment
Persistent link
https://www.medvik.cz/link/pmid38851424
PubMed
38851424
DOI
10.1016/j.cmi.2024.06.001
PII: S1198-743X(24)00277-5
Knihovny.cz E-resources
- Keywords
- BPaLM availability, Bedaquline testing, MDR-TB, MDR-TB testing in EU/EAA, Pretomanid testing,
- MeSH
- Antitubercular Agents * therapeutic use pharmacology MeSH
- Humans MeSH
- Microbial Sensitivity Tests * MeSH
- Tuberculosis, Multidrug-Resistant * drug therapy diagnosis microbiology MeSH
- Mycobacterium tuberculosis drug effects genetics MeSH
- Rifampin * therapeutic use pharmacology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Comment MeSH
- Geographicals
- Europe MeSH
- Names of Substances
- Antitubercular Agents * MeSH
- Rifampin * MeSH
References provided by Crossref.org
